Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(25%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
3
25%
Ph phase_2
5
42%
Ph not_applicable
4
33%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
5(41.7%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
Recruiting3
unknown3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (25.0%)
Phase 25 (41.7%)
N/A4 (33.3%)

Trials by Status

recruiting325%
withdrawn18%
completed433%
unknown325%
terminated18%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
12